113 related articles for article (PubMed ID: 6399129)
21. [A woman with fever, lymphadenomegaly, hepatosplenomegaly, leukocytoclastic vasculitis, pancytopenia, and intravascular coagulation].
Hernández-Cruz B; Velázquez Ceceña JL
Rev Invest Clin; 1996; 48(6):465-72. PubMed ID: 9132892
[No Abstract] [Full Text] [Related]
22. Erythema elevatum diutinum associated with lupus panniculitis in a patient with discoid lesions of chronic cutaneous lupus erythematosus.
Hancox JG; Wallace CA; Sangueza OP; Graham GF
J Am Acad Dermatol; 2004 Apr; 50(4):652-3. PubMed ID: 15034527
[No Abstract] [Full Text] [Related]
23. [Stevens-Johnson syndrome and toxic epidermal necrolysis; therapy policy in these life-threatening illnesses. Netherlands Work Group Toxic Epidermal Necrolysis].
van der Meer JB
Ned Tijdschr Geneeskd; 1996 Jul; 140(30):1538-43. PubMed ID: 8765761
[No Abstract] [Full Text] [Related]
24. Practical guidelines for the management of toxic epidermal necrolysis and Stevens-Johnson syndrome.
Fromowitz JS; Ramos-Caro FA; Flowers FP;
Int J Dermatol; 2007 Oct; 46(10):1092-4. PubMed ID: 17910723
[TBL] [Abstract][Full Text] [Related]
25. [Severe skin reactions. Toxic epidermal necrolysis, Stevens-Johnson syndrome, erythema exsudativum multiforme majus and generalized bullous fixed drug exanthema].
Rzany B; Mockenhaupt M; Baur S; Stocker U; Schöpf E
Hautarzt; 1993 Aug; 44(8):549-54; quiz 554-6. PubMed ID: 8376113
[No Abstract] [Full Text] [Related]
26. Plasma activity of interleukin-6 and some acute phase proteins in severe drug-induced skin adverse reactions.
Czelej D; Chodorowska G; Lecewicz-Toruń B
Ann Univ Mariae Curie Sklodowska Med; 2002; 57(2):62-7. PubMed ID: 12898820
[TBL] [Abstract][Full Text] [Related]
27. Activity of Tumor Necrosis Factor-alpha (TNF-alpha) and its soluble type I receptor (p55TNF-R) in some drug-induced cutaneous reactions.
Chodorowska G; Czelej D; Niewiedzioł M
Ann Univ Mariae Curie Sklodowska Med; 2003; 58(2):50-6. PubMed ID: 15323166
[TBL] [Abstract][Full Text] [Related]
28. [Toxic epidermal necrolysis and Stevens-Johnson syndrome].
Roujeau JC
Rev Prat; 2007 Jun; 57(11):1165-70. PubMed ID: 17691257
[TBL] [Abstract][Full Text] [Related]
29. Stevens-Johnson syndrome and toxic epidermal necrolysis.
Prendiville J
Adv Dermatol; 2002; 18():151-73. PubMed ID: 12528405
[No Abstract] [Full Text] [Related]
30. [Management of cutaneous risk in pharmacovigilance: metabolic predisposition to Stevens-Johnson syndromes and toxic epidermal necrolysis].
Wolkenstein P
Therapie; 1996; 51(5):500-1. PubMed ID: 9138383
[No Abstract] [Full Text] [Related]
31. [Toxic epidermal necrolysis (syndrome Lyell) versus Stevens-Johnson syndrome].
Jezierska-Krupa B; Hyla-Klekot L
Pediatr Pol; 1996 Jul; 71(7):615-20. PubMed ID: 8803466
[TBL] [Abstract][Full Text] [Related]
32. Toxic epidermal necrolysis and Stevens-Johnson syndrome: soluble Fas ligand involvement in the pathomechanisms of these diseases.
Abe R
J Dermatol Sci; 2008 Dec; 52(3):151-9. PubMed ID: 18657400
[TBL] [Abstract][Full Text] [Related]
33. [Interrelation of erythema multiforme exudativum, the Stevens-Johnson syndrome and toxic epidermal necrolysis (Lyell's syndrome)].
Anton'eva AA; Shevarova VN
Vestn Dermatol Venerol; 1981 Jul; (7):29-30. PubMed ID: 7293469
[No Abstract] [Full Text] [Related]
34. Serum electrophoretic patterns in vitiligo, psoriasis and discoid lupus erythematosus.
Ramasastry CV; Dutta AK; Banerjee BN
Indian J Dermatol; 1978 Oct; 24(1):7-12. PubMed ID: 757701
[No Abstract] [Full Text] [Related]
35. Disseminated intravascular coagulation associated with toxic epidermal necrolysis (Lyell's syndrome).
Kvasnicka J; Rezác J; Svejda J; Duchková H; Kaze F; Zalud P; Richter J
Br J Dermatol; 1979 May; 100(5):551-8. PubMed ID: 444427
[TBL] [Abstract][Full Text] [Related]
36. Allopurinol-induced Stevens-Johnson syndrome and toxic epidermal necrolysis.
Lee HY; Pang SM; Thamotharampillai T
J Am Acad Dermatol; 2008 Aug; 59(2):352-3. PubMed ID: 18638633
[No Abstract] [Full Text] [Related]
37. Incidence of Stevens-Johnson syndrome and toxic epidermal necrolysis in patients with the acquired immunodeficiency syndrome in Germany.
Rzany B; Mockenhaupt M; Stocker U; Hamouda O; Schöpf E
Arch Dermatol; 1993 Aug; 129(8):1059. PubMed ID: 8352614
[No Abstract] [Full Text] [Related]
38. Pentoxyfylline in toxic epidermal necrolysis and Stevens-Johnson syndrome.
Sanclemente G; De la Roche CA; Escobar CE; Falabella R
Int J Dermatol; 1999 Nov; 38(11):878-9. PubMed ID: 10583942
[No Abstract] [Full Text] [Related]
39. Serum interleukin-13 levels are increased in patients with Stevens-Johnson syndrome/ toxic epidermal necrolysis but not in those with erythema multiforme.
Quaglino P; Caproni M; Osella-Abate S; Torchia D; Comessatti A; Del Bianco E; Antiga E; Frezzolini A; Schena D; Marzano A; De Simone C; Parodi A; Fabbri P; Bernengo MG
Br J Dermatol; 2008 Jan; 158(1):184-6. PubMed ID: 17941938
[No Abstract] [Full Text] [Related]
40. Stevens-Johnson syndrome and toxic epidermal necrolysis-challenges of recognition and management.
Sane SP; Bhatt AD
J Assoc Physicians India; 2000 Oct; 48(10):999-1003. PubMed ID: 11200928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
